Community series in combinational immunotherapy of cancer: novel targets, mechanisms, and strategies, volume II

被引：0
|
作者：
Xu, Caili
Ju, Dianwen [1 ]
Zhang, Xuyao [1 ]
机构：
[1] Fudan Univ, Sch Pharm, Dept Biol Med, Shanghai, Peoples R China
来源：
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金：
中国国家自然科学基金;
关键词：
cancer immunotherapy; tumor microenvironment; biomarker; therapeutic target; chimeric antigen receptor T-cells;
D O I：
10.3389/fimmu.2023.1256691
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Editorial: Community series in tumor ablation and immunity, volume II
    Xiao, Yueyong
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [42] Community series in advances in pathogenesis and therapies of gout, volume II
    Duan, Lihua
    Zhong, Jixin
    Yang, Ye
    Liu, Yuan
    Zhu, Xiaoxia
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [43] Editorial: Community series in primary immunodeficiencies worldwide, volume II
    Condino-Neto, Antonio
    Korganow, Anne-Sophie
    Kanegane, Hirokazu
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [44] Editorial: Community series in ethics in psychiatry and psychotherapy - Volume II
    Geppert, Cynthia M. A.
    Brendel, Rebecca Weintraub
    Trachsel, Manuel
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [45] Editorial: Community series in immunoregulation at mucosal surfaces volume II
    Leceta, Javier
    Klose, Christoph S. N.
    Jordan, Stefan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [46] Male idiopathic infertility: Novel possible targets, volume II
    Cannarella, Rossella
    Jezek, Davor
    Condorelli, Rosita A.
    Calogero, Aldo E.
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [47] Novel Strategies for Redirecting NK Cells in Cancer Immunotherapy
    Yi Mei
    Bo Xiang
    Jianbo Yang
    Journal of Nutritional Oncology, 2017, 2 (02) : 66 - 72
  • [48] Tumor neoantigens: Novel strategies for application of cancer immunotherapy
    Guan, Hanyang
    Wu, Yue
    Li, Lu
    Yang, Yabing
    Qiu, Shenghui
    Zhao, Zhan
    Chu, Xiaodong
    He, Jiashuai
    Chen, Zuyang
    Zhang, Yiran
    Ding, Hui
    Pan, Jinghua
    Pan, Yunlong
    ONCOLOGY RESEARCH, 2023, 31 (04) : 437 - 448
  • [49] MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy
    Cornel, Annelisa M.
    Mimpen, Iris L.
    Nierkens, Stefan
    CANCERS, 2020, 12 (07) : 1 - 33
  • [50] Results of the safety evaluation of cancer vaccines dealing with novel targets for cancer immunotherapy
    Mancebo, A.
    Bada, A. M.
    Casaco, A.
    Gonzalez, B.
    Leon, A.
    Arteaga, M. E.
    Gonzalez, C.
    Sanchez, B.
    Carr, A.
    Ledon, N.
    Iglesias, A.
    TOXICOLOGY LETTERS, 2016, 259 : S151 - S152
12345